Mortality and renal outcomes of patients with severe COVID-19 treated in a provisional intensive care unit

J Crit Care. 2021 Apr:62:172-175. doi: 10.1016/j.jcrc.2020.12.012. Epub 2020 Dec 19.

Abstract

COVID-19 has created an enormous health crisis and this spring New York City had a severe outbreak that pushed health and critical care resources to the limit. A lack of adequate space for mechanically ventilated patients induced our hospital to convert operating rooms into critical care areas (OR-ICU). A large number of COVID-19 will develop acute kidney injury that requires renal replacement therapy (RRT). We included 116 patients with COVID-19 who required mechanical ventilation and were cared for in our OR-ICU. At 90 days and at discharge 35 patients died (30.2%). RRT was required by 45 of the 116 patients (38.8%) and 18 of these 45 patients (40%) compared to 17 with no RRT (23.9%, ns) died during hospitalization and after 90 days. Only two of the 27 patients who required RRT and survived required RRT at discharge and 90 days. When defining renal recovery as a discharge serum creatinine within 150% of baseline, 68 of 78 survivors showed renal recovery (87.2%). Survival was similar to previous reports of patients with severe COVID-19 for patients cared for in provisional ICUs compared to standard ICUs. Most patients with severe COVID-19 and AKI are likely to recover full renal function.

Keywords: Acute kidney injury; COVID-19; Long-term outcomes; Provisional ICU.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Acute Kidney Injury / etiology*
  • Acute Kidney Injury / mortality*
  • Acute Kidney Injury / therapy*
  • Aged
  • COVID-19 / complications*
  • COVID-19 / mortality*
  • Cohort Studies
  • Female
  • Hospitalization
  • Humans
  • Intensive Care Units / supply & distribution
  • Male
  • Middle Aged
  • New York City / epidemiology
  • Recovery of Function
  • Renal Replacement Therapy*
  • Respiration, Artificial
  • Retrospective Studies
  • SARS-CoV-2